1. Home
  2. QURE

as 07-15-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Founded: 1998 Country:
Netherlands
Netherlands
Employees: N/A City: AMSTERDAM
Market Cap: 432.6M IPO Year: 2007
Target Price: $23.00 AVG Volume (30 days): 7.1M
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -6.21 EPS Growth: N/A
52 Week Low/High: $3.73 - $11.35 Next Earning Date: 07-30-2024
Revenue: $19,003,000 Revenue Growth: -82.73%
Revenue Growth (this year): 265.61% Revenue Growth (next year): 74.54%

QURE Daily Stock ML Predictions

Stock Insider Trading Activity of uniQure N.V. (QURE)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
CALOZ PIERRE QURE Chief Operating Officer Jun 17 '24 Sell $4.81 2,936 $14,122.16 115,707 SEC Form 4
Jacques Rachelle Suzanne QURE Director Jun 13 '24 Sell $5.14 2,221 $11,415.94 14,408 SEC Form 4
Soteropoulos Paula QURE Director Jun 13 '24 Sell $5.14 2,220 $11,410.80 20,203 SEC Form 4
POST LEONARD E QURE Director Jun 13 '24 Sell $5.14 2,222 $11,421.08 15,999 SEC Form 4
Potts Jeannette QURE Chief Legal Officer Jun 13 '24 Sell $4.98 4,781 $23,809.38 91,819 SEC Form 4
Meek David D. QURE Director Jun 13 '24 Sell $5.12 2,229 $11,412.48 20,252 SEC Form 4
Kaye Jack QURE Director Jun 13 '24 Sell $5.16 2,218 $11,444.88 6,501 SEC Form 4
CALOZ PIERRE QURE Chief Operating Officer Feb 26 '24 Sell $6.47 9,455 $61,173.85 85,643 SEC Form 4
Kapusta Matthew C QURE CEO, Managing Director Feb 26 '24 Sell $6.35 27,904 $177,190.40 440,839 SEC Form 4
KLEMT CHRISTIAN QURE Chief Financial Officer Feb 26 '24 Sell $6.38 15,906 $101,480.28 116,948 SEC Form 4

Share on Social Networks: